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Aβ	 Large	 Myelinated	 >14	 Light	touch	and	brush	 Innocuous	 Pain	(allodynia)	
Aδ	Type	I	 Medium	 Partly	Myelinated	 2.2-8	 Noxious	mechanical	 Nociceptive	 Exaggerated	pain	(hyperalgesia)	
Aδ	Type	II	 Medium	 Partly	Myelinated	 2.2-8	 Noxious	thermal	 Nociceptive	 Exaggerated	pain	(hyperalgesia)	


























































































































































































































































































































































































































































































Pre-Incubation	 95	 00:05:00	 4.8	 1	 None	
Amplification	 95	 00:00:10	 4.8	 45	 Quantification	72	 00:00:30	 4.8	
Melting	Curve	 95	 00:00:05	 4.8	 1	 Melting	Curves	65	 00:01:00	 2.5	97	 -	 -	




































































































































































































































































































































































































































































































































































































































































































































































































































































































N/A	 1. The	α2-adrenergic	receptor	antagonists	atipamezole	and	yohimbine	block	DNIC	expression	in	naïve	animals.	2. The	NRIs	Reboxetine	and	Tapentadol	restored	DNIC	expression	in	an	SNL	model	of	neuropathy.	3. Descending	inhibitory	noradrenergic	controls	are	downregulated	in	animal	models	of	neuropathic	and	MIA	induced	chronic	pain.	
1. Spinal	5-HT7	receptors	play	an	antinocicptive	role	in	neuropathic	and	inflammatory	animal	models.	2. Spinal	5-HT7	receptors	are	colocalised	with	GABAergic	cells	–may	mediate	neuronal	inhibition	through	activation	of	inhibitory	interneurons.		3. Increased	density	of	5-HT7	receptors	following	neuropathy	–	potential	for	modulation	of	this	system	in	chronic	pain.		
References	 N/A	 1. Bannister	et	al	2015	2. Bannister	et	al	2015	3. Rahman	et	al	2008,	Burnham	and	Dickenson	2013.	

























Early	phase	MIA	 Late	phase	MIA	 Other	studies	 References	
Joint	
Histopathology	
Little	articular	cartilage	degradation.	
Significant	articular	cartilage	degradation	and	exposure	of	subchondral	bone.	
14	days	post-injection:	Severe	cartilage	damage	and	proteoglycan	loss.		Initial	damage	to	subchondral	bone,	including	sclerosis,	fragmentation,	bone	lesions.	
Guingamp	et	al	1997	Guzman	et	al	2003			Mohan	et	al	2011	
Peripheral	
Inflammation	
No	increase	in	mRNA	expression	of	pro-inflammatory	cytokines	in	ipsilateral	lumbar	DRGs.	
No	increase	in	mRNA	expression	of	pro-inflammatory	cytokines	in	ipsilateral	lumbar	DRGs.	
Significant	inflammatory	infiltrate	in	joint	soft	tissue	structures	in	early	phase	MIA	animals,	which	declines	over	time.	
Guzman	et	al	2003	Clements	et	al	2009		Orita	et	al	2011	
Peripheral	
nerve	damage	
No	ATF-3	positive	staining	in	ipsilateral	lumbar	DRGs.	
No	ATF-3	positive	staining	in	ipsilateral	lumbar	DRGs.	
A	significant	increase	in	the	number	of	ATF-3	positive	cell	bodies	in	L4	and	L5	DRGs,	3,	7	and	14	days	post	MIA	injection.		A	significant	increase	in	ATF-3	positive	cell	bodies	in	L4	DRG	14	days	post	injection.		ATF-3	staining	observed	in	2.1%	of	L3,	L4	and	L5	DRG	cells	7	days	post	injection.	
Thakur	et	al	2012								Orita	et	al	2011						Ogbonna	et	al	2013	
Sensitivity	of	
dorsal	horn	
neurons	
No	increase	in	mechanically	evoked	WDR	
No	increase	in	mechanically	evoked	WDR	
Enhanced	WDR	neuronal	firing	rates	in	response	to	
Rahman	et	al	2009	Burnham	and	
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neuronal	firing	rates	compared	to	sham	controls.	
neuronal	firing	rates	compared	to	sham	controls.	
noxious	stimulations.	Enhanced	spontaneous	firing	rate	of	WDR	neurons.		
Dickenson	2013	McGaraughty	et	al	2010	Chu	et	al	2011	
Microgliosis	 No	significant	increase	in	the	mRNA	expression	of	Iba1	or	pro-inflammatory	cytokines	in	the	dorsal	horn.	
A	rise	in	the	mRNA	expression	of	Iba1	and	the	pro-inflammatory	cytokine	IL-1β,	but	this	did	not	reach	significance.	
Significant	shift	of	microglia	into	effector	morphometry	by	day	7.	Significant	proliferation	of	microglia	in	the	ipsilaterl	lumbar	spinal	cord.			
Thakur	et	al	2012			Sagar	et	al	2011	Ogbonna	et	al	2013	
Functionality	of	
descending	
controls	
Functional	DNIC	expression.	 Abolished	DNIC	expression.	 Endogenous	noradrenergic	inhibition	was	reduced	in	late	phase	MIA	animals.		Enhanced	serotonergic	excitatory	drive	modulates	evoked	neuronal	responses	in	late	phase	MIA	animals.	
Burnham	and	Dickenson	2013					Rahman	et	al	2009	
		
7.3	Methodological	considerations		While	the	preclinical	investigation	of	animal	models	of	chronic	pain	expands	our	understanding	of	the	neurobiology	of	pain	and	provides	useful	insights	into	the	molecular	mechanisms	of	effective	analgesics,	any	differentiations	between	animal	and	human	pathways	needs	to	be	considered.	An	awareness	of	the	limitations	of	each	experimental	technique	will	allow	for	the	most	accurate	conclusions	to	be	drawn,	and	for	appropriate	translation	from	preclinical	models	to	the	clinic.		
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7.3.1	Single-unit	in	vivo	recordings	
	
7.3.1.1	The	use	of	supra	threshold	stimulations	Single	unit	in	vivo	recordings	provide	a	useful	technique	for	unbiased	measurements	of	neuronal	responses	to	natural	and	electrical	stimulations,	and	in	turn	an	understanding	of	how	these	responses	can	be	modulated	by	pharmacological	manipulation	in	animal	models	of	chronic	pain.	Many	other	experimental	techniques	used	in	animals	models	of	preclinical	pain	research,	such	as	behaviour	and	electromyographic	recordings,	measure	nociceptive	responses	based	on	reflex	withdrawals,	yet	it	remains	questionable	how	reliably	reflex	withdrawals	reflect	the	human	pain	experience	(Mogil	2009).	In	addition,	behavioural	techniques	only	allowing	for	threshold	level	stimulations	due	to	ethical	reasons,	there	is	a	also	a	subjective	nature	to	the	tests,	which	may	introduce	bias.	In	contrast,	single-unit	in	vivo	recordings	allows	for	measurements	of	neuronal	responses	to	supra	threshold	stimuli,	which	are	likely	to	reflect	the	high	pain	levels	reported	by	patients	in	the	clinic	(Sikander	and	Dickenson	2013).			
7.3.1.2	The	search	strategy	for	neurones	There	are	limitations	to	single	unit	in	vivo	recordings	that	should	be	taken	into	consideration.	Firstly,	the	strategy	employed	for	finding	neurons	ensures	a	sample	of	neurons	are	selected	with	similar	characteristics,	and	whilst	this	allows	for	comparisons	between	studies	it	may	also	introduce	bias.	For	example,	neurones	with	a	high	level	of	baseline	spontaneous	activity	tend	to	be	excluded	from	studies	as	they	are	highly	excitable	and	are	likely	to	burst	following	a	few	noxious	stimulations	to	the	receptive	field.	In	addition,	a	high	level	of	tonic	spontaneous	activity	makes	it	difficult	to	distinguish	between	spontaneous	and	evoked	action	potentials,	and	therefore	makes	DNIC	induced	neuronal	inhibition	difficult	to	interpret.	However,	WDR	neurons	receiving	input	from	both	the	knee	and	hind	paw	in	MIA	animals	have	been	demonstrated	to	have	an	enhanced	spontaneous	firing	rate	compared	to	Shams	(McGaraughty	et	al	2010,	Chu	et	al	2011).	Therefore,	excluding	neurons	with	high	levels	of	spontaneous	firing	may	produce	an	underestimation	of	central	sensitisation	in	MIA	animals.	This	may	provide	one	explanation	for	why	mechanically	evoked	neuronal	responses	were	not	found	to	be	enhanced	compared	to	shams	in	this	thesis.			
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7.3.1.3	Descending	controls	and	anaesthesia	It	has	previously	been	considered	that	for	CPM,	the	conditioning	stimulus	may	attenuate	the	pain	response	partly	through	a	distraction	mechanism.	However,	human	studies	have	confirmed	that	the	CPM	system	acts	independently	from	distraction	(Moont	et	al	2010).	The	results	presented	in	this	thesis	with	anaesthetized	animals	provide	unequivocal	evidence	that	the	noxious	conditioning	stimulus	induces	neuronal	inhibition	through	a	mechanism	that	does	not	involve	distraction.	As	the	low	level	of	anaesthesia	used	is	constant	for	the	duration	of	the	experiment,	and	the	same	levels	are	used	between	animals,	any	anaesthesia-induced	reduction	in	spinal	neuronal	activity	should	also	remain	constant	and	allows	for	comparisons	between	studies.	However,	when	using	recordings	from	anaesthetized	animals,	the	effect	anesthesia	may	have	on	descending	modulation	needs	to	be	considered,	especially	when	taking	into	account	that	isoflurane	has	been	reported	to	mediate	antinociception	through	noradrenergic	descending	controls	acting	at	spinal	α2-adrenergic	receptors	(Kingery	et	al	2002).	If	isoflourane	were	modulating	descending	controls	through	this	mechanism,	outcomes	may	have	to	be	interpreted	more	carefully.	However,	the	alterations	observed	in	the	descending	noradrenergic	system	in	late	phase	MIA	and	SNL	animals	compared	to	shams,	when	all	animals	are	under	the	same	level	of	isoflurane	indicates	that	isoflurane	is	not	modulating	descending	noradrenergic	activity	enough	to	effect	DNIC	repsonses.	Furthermore,	the	potent	effects	produced	by	the	α2-adrenergic	receptor	antagonist	atipamezole	and	the	NRIs	Reboxetine	and	Tapentadol	suggests	there	is	little	competition	for	spinal	α2-adrenergic	receptors,	further	indicating	isoflurane	is	not	be	having	a	large	effect	on	these	receptors.			
7.3.1.4	The	DNIC	protocol	In	the	MIA	model,	DNIC	was	induced	with	both	a	concurrent	noxious	ear	pinch	and	knee	pinch.	The	concurrent	noxious	pinch	was	placed	on	the	MIA	injured	knee	to	assess	if	noxiously	stimulating	the	area	of	primary	hyperalgesia	could	induce	neuronal	inhibition.	However,	in	both	animal	DNIC	studies	and	human	CPM	paradigms	the	conditioning	stimulus	is	placed	distant	to	the	test	stimulus	(Bannister	and	Dickenson	2016a,	Yarnitsky	2015).	Therefore,	as	the	test	stimulus	is	placed	on	the	receptive	field	of	the	hind	paw,	and	the	concurrent	conditioning	stimulus	is	placed	on	the	ipsilateral	MIA	injured	knee,	these	two	sites	may	be	too	close	to	constitute	a	DNIC	response.	As	such,	the	inhibition	observed	in	neuronal	firing	upon	concurrent	noxious	MIA	injured	knee	pinch	in	late	phase	MIA	animals,	who	otherwise	demonstrate	an	abolished	DNIC	system,	may	be	due	to	other	mechanisms	rather	than	DNIC.	However,	DNIC	is	abolished	in	both	
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ipsilateral	and	contralateral	WDR	neurons	in	late	phase	MIA	animals.	Therefore,	the	DNIC	expression	was	also	assessed	in	contralateral	cells	with	a	concurrent	noxious	pinch	placed	on	the	MIA	injured	knee,	which	is	now	contralateral	to	the	hind	paw	receptive	field	and	would	count	as	a	distant	site.			
7.3.2	The	MIA	model	As	discussed	in	Section	5.1.1,	although	it	is	difficult	to	mimic	the	exact	aetiology	of	OA	in	an	animal	model,	the	2mg	MIA	model	produces	similar	joint	pathology,	associated	pain-behaviour	and	evidence	of	central	sensitisation.	Although	there	is	an	initial	inflammatory	infiltrate	into	the	joint	rapidly	following	MIA	injection,	the	inflammatory	response	begins	to	subside	by	day	7	and	continues	to	stay	low	at	the	later	stages	of	the	model	(Guzman	et	al	2003,	Orita	et	al	2011).	In	contrast,	although	a	higher	inflammatory	infiltrate	was	found	in	joint	tissue	from	patients	with	early	phase	OA,	patients	present	with	episodic	synovial	inflammation,	which	occurs	in	both	the	early	and	late	stages	of	the	disease	(Benito	et	al	2005,	Scanzello	and	Goldring	2012).	Therefore,	although	the	inflammatory	response	occurring	in	the	early	stages	of	the	MIA	model	represents	similarities	with	the	human	OA	condition,	the	fact	that	late	phase	MIA	models	develop	NSAID	insensitive	ongoing	pain	may	not	necessarily	be	reflective	of	patients	(Fernihough	et	al	2004,	Havelin	et	al	2016).	While	NSAIDs	may	prove	generally	ineffective	in	patients	with	advanced	OA,	they	may	prove	beneficial	in	OA	patients	undergoing	a	synovitis	flare,	which	can	be	detected	through	MRI	or	ultrasound	imaging	of	the	joint	(Scanzello	and	Goldring	2012).	Overall,	while	the	late	phase	MIA	model	shares	similar	structural	joint	changes	with	OA	patients,	it	may	not	characterize	inflammatory	flares	observed	in	OA	patients,	and	therefore	may	not	be	a	perfect	model	for	forward	translation	to	the	clinic	in	every	case.		
	
7.3.3	MIA	induced	histopathology	of	the	knee	While	cartilage	damage	has	long	been	considered	the	central	feature	for	initiating	OA,	and	MIA	was	shown	to	significantly	damage	articular	cartilage	in	late	phase	animals,	it	is	becoming	increasingly	clear	that	OA	should	be	considered	a	disease	of	the	whole	joint	(Loeser	2006,	Dieppe	2011).	Although	the	knee	histology	presented	in	this	thesis	showed	significant	degradation	of	the	articular	cartilage	and	exposure	of	subchondral	bone	in	late	phase	MIA	animals,	it	did	not	assess	any	damage	to	the	synovium,	subchondral	bone	or	surrounding	joint	structures,	such	as	the	muscles	and	ligaments.	Although	the	specific	OA	induced	joint	damage	varies	greatly	between	patients,	damage	can	occur	in	all	subchondral	joint	structures	and	contribute	to	the	development	of	
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disease	pathogenesis	(Wieland	et	al	2005)(See	Section	1.3.2).	As	this	thesis	explores	the	chronic	pain	associated	with	OA,	and	the	cartilage	itself	is	not	innervated	and	so	cannot	be	causing	pain	directly,	it	may	be	beneficial	to	use	a	method	that	allows	for	assessing	damage	to	the	whole	joint.	Furthermore,	one	feature	of	OA	induced	joint	damage	associated	with	flares	of	chronic	pain	in	patients	is	bone	marrow	lesions	(Felson	et	al	2001,	Zhang	et	al	2011).	Therefore,	a	technique	such	as	microCT,	which	is	capable	of	detecting	subchondral	joint	damage,	may	allow	for	a	clearer	understanding	of	what	may	be	driving	the	associated	chronic	pain	and	central	sensitisation	in	the	MIA	model	(Morenko	et	al	2004).	Overall,	assessing	the	damage	caused	by	MIA	to	the	joint	as	a	whole	may	provide	valuable	insights	on	how	translatable	the	MIA	induced	joint	damage	is	compared	to	OA	induced	joint	damage	in	patients.			
7.3.4	The	limitations	of	qPCR	In	this	thesis,	changes	in	the	mRNA	expression	of	monoaminergic	receptors,	glia	biomarkers,	pro-inflammatory	cytokines,	and	nerve	injury	markers	were	assessed	in	the	ipsilateral	lumbar	DRGs	and	dorsal	horn	using	qPCR.	While	little	changes	in	the	mRNA	expressions	were	reported	in	this	thesis,	it	should	be	considered	that	this	might	due	to	a	dilution	effect.	Firstly,	the	whole	of	the	lumbar	dorsal	horn	was	taken	and	used	for	RNA	extraction,	while	changes	in	mRNA	expression	may	occur	in	a	specific	areas	of	the	dorsal	horn.	Secondly,	the	cellular	heterogeneity	of	the	DRGs	and	dorsal	horn	should	be	taken	into	account.	When	investigating	monoaminergic	receptors	and	nerve	injury	markers,	the	interest	was	specifically	based	on	changes	to	mRNA	expression	in	the	neurons.	However,	in	the	dorsal	horn	the	glia	cells	alone	outnumber	neurons	ten	to	one	(McMahon	and	Koltzberg	2013).	Similarly,	it	has	been	demonstrated	that	from	a	dissociated	preparation	of	whole	ganglia,	10%	of	the	composition	constitutes	a	mixture	of	neuronal	cells,	while	the	remaining	90%	of	this	preparation	is	made	up	of	satellite	ganglia	and	other	non-neuronal	cell	types	(Thakur	et	al	2014b).	When	it	is	considered	that	only	certain	neurons	will	express	the	receptor	of	interest,	this	dilutes	the	chances	of	seeing	an	effect	further	still.	One	method	that	could	be	employed	to	remove	the	diluting	effect	would	be	to	separate	the	neurons	from	the	rest	of	the	tissue.	A	magnetic	purification	technique	has	been	demonstrated	to	achieve	this	in	DRG	tissues,	while	a	single	nucleus	RNA-sequencing	technique	can	provide	identification	of	neuronal	populations	in	the	spinal	cord	(Thakur	et	al	2014b,	Sathyamurthy	et	al	2018).	Overall,	it	should	be	considered	that	the	lack	of	significant	differences	observed	with	qPCR	in	this	thesis	does	not	necessarily	mean	there	were	no	changes	to	receptor	expression	in	the	
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neurons,	it	may	just	be	that	the	effect	was	too	small	to	be	detected	in	whole	tissue	preparations.			
7.4	Future	studies	This	thesis	demonstrated	that	testing	the	functionality	of	DNIC	using	in	vivo	single	unit	recordings	of	convergent	WDR	neurons	provides	a	robust	and	reliable	technique	for	assessing	the	function	of	descending	controls	in	animal	models	of	chronic	pain.	This	thesis	further	demonstrates	that	in	the	late	phase	MIA	model	of	OA,	where	there	is	substantial	cartilage	damage,	the	DNIC	system	is	abolished	due	to	an	imbalance	in	descending	inhibitory	and	facilitatory	controls.	In	addition	to	the	amendments	to	the	experimental	techniques	discussed	above,	further	studies	could	be	carried	out	to	better	understand	the	exact	molecular	mechanisms	underlying	the	joint	damage	induced	barrage	of	nociceptive	information	and	the	subsequent	imbalance	in	descending	controls	and	abolished	DNIC	expression.			
7.4.1	The	contribution	of	joint	damaged	induced	peripheral	nociceptive	
drive	and	the	dysfunctional	DNIC	system	This	thesis	demonstrated	that	significant	cartilage	damage	was	not	observed	until	the	late	phase	of	the	MIA	model,	and	that	a	longer	time	course	of	the	model	may	provide	a	tool	for	further	exploration	of	subchondral	bone	damage	induced	central	changes.	Interestingly,	DNIC	expression	is	abolished	as	the	model	progresses	to	14	days.	It	has	previously	been	demonstrated	that	the	DNIC	system	is	lost	in	a	SNL	rat	model	of	neuropathy	(Bannister	et	al	2015,	Bannister	et	al	2017).	However,	and	as	the	articular	cartilage	is	not	innervated	and	no	other	signs	of	neuropathy	were	detected	in	the	MIA	model	in	this	thesis,	it	suggests	that	the	modulation	of	descending	inhibitory	and	facilitatory	controls	and	the	subsequent	abolished	DNIC	expression	can	occur	in	other	pain	models,	even	without	neuropathy.				A	substantial	inflammatory	infiltrate	has	been	demonstrated	in	early	phase	MIA	animals	and	in	OA	patients,	and	it	should	be	considered	that	this	could	be	responsible	for	the	development	of	peripheral	sensitisation	(Guzman	et	al	2003,	Clements	et	al	2009,	Scanzello	and	Goldring	2012).	Furthermore,	the	barrage	of	nociceptive	signals	from	the	periphery	and	the	subsequent	continuous	stimulation	of	second	order	neurons	may	result	in	sensitisation	of	dorsal	horn	neurons	(Woolf	2011).	Therefore,	it	would	be	interesting	to	assess	how	inhibiting	this	peripheral	nociceptive	drive	early	in	the	MIA	
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model	impacts	the	development	of	central	sensitisation	and	the	subsequent	imbalance	in	descending	controls.			Firstly,	NSAIDs	are	effective	at	providing	pain	relief	in	early	phase	MIA	animals	(Fernihough	et	al	2004,	Havelin	et	al	2016).	Similarly,	NSAIDs	provide	effective	analgesia	in	the	early	stages	of	OA	in	patients,	through	preventing	the	synthesis	of	prostaglandins	and	preventing	peripheral	sensitisation	that	arises	due	to	the	inflammatory	component	of	OA	(Lin	et	al	2004,	Wieland	et	al	2005).	Secondly,	the	neurotrophin	NGF	is	part	of	the	‘inflammatory	soup’	produced	in	response	to	tissue	damage	and	is	thought	to	contribute	to	peripheral	sensitisation	as	it	sensitizes	TRPV1	channels	on	peptidergic	C	fibres,	especially	in	inflammatory	conditions	such	as	OA	(McMahon	1996).	In	addition,	the	NGF	neutralizing	antibody	Tanezumab	has	been	demonstrated	to	reduce	joint	pain	in	patients	with	moderate	to	severe	OA	of	the	knee	joint	(Lane	et	al	2010).	An	interesting	approach	for	assessing	the	impact	of	peripheral	sensitisation	could	be	to	induce	MIA	damage	and	then	apply	topical	NSAIDs	or	NGF	neutralizing	antibodies	to	the	knee	and	assess	if	the	DNIC	system	still	becomes	dysfunctional.	This	could	provide	valuable	insights	for	treatment	options	in	the	clinic	and	address	the	option	of	targeting	the	peripheral	component	early	on	disease	pathogenesis	with	the	aim	to	prevent	the	development	of	centrally	driven	chronic	pain.		
7.4.2	Further	assessing	DNIC	pharmacology	at	the	level	of	the	spinal	cord	As	discussed	in	Chapter	4,	the	descending	serotonergic	system	exerts	a	bi-directional	role	on	pain	processing	as	both	inhibitory	and	facilitatory	actions	have	been	demonstrated	upon	5-HT	release	in	the	dorsal	horn.	There	are	a	myriad	of	serotonergic	receptors	in	the	spinal	cord,	and	the	overall	pronociceptive	or	antinociceptive	action	of	descending	serotonergic	controls	depends	upon	the	receptors	subtypes	activated.	The	role	of	spinal	5-HT3	receptors	in	pain	transmission	have	been	extensively	studied,	and	play	a	facilitatory	role	in	pain	processing	in	MIA	animals	(Rahman	et	al	2009).	Furthemore,	blocking	the	actions	of	5-HT	at	spinal	5-HT3	receptors	restores	DNIC	in	a	model	of	neuropathy	(Bannister	et	al	2015).	This	thesis	investigated	the	tole	of	spinal	5-HT7	receptors	in	pain	transmission.	The	spinal	co-administration	of	the	5-HT7	receptor	antagonist	SB-267790	completely	blocked	the	inhibitory	actions	of	the	SSRIs	fluoxetine	and	citalopram,	which	indicates	a	principal	role	of	this	receptor	in	mediating	serotonergic	inhibition	(Bannister	et	al	2017).	These	findings	agree	with	previous	studies,	that	spinal	5-HT3	receptors	mediate	facilitation,	while	spinal	5-HT7	receptors	mediate	and	inhibition	of	the	pain	response	(Dogrul	and	and	Seyrek	2006,	Dogrul	et	al	
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2009).	However,	it	would	be	interesting	to	use	antagonists	and	agonists	for	the	remaining	spinal	serotonergic	receptors	in	early	and	late	phase	animals	to	better	understand	the	specific	roles	of	each	receptor	in	the	expression	of	DNIC.			
7.4.3	The	brain	areas	involved	in	the	development	of	a	dysfunctional	DNIC	
system	As	the	DNIC	system	is	lost	following	spinal	transection,	it	indicates	that	DNIC	requires	supraspinal	signals	and	the	activation	of	functional	descending	controls,	however	the	exact	brain	signaling	pathways	required	for	the	expression	of	DNIC	are	yet	to	be	conclusively	determined	(Le	Bars	et	al	1979b,	Dickenson	and	Le	Bars	1983).	Changes	in	the	level	of	activity	in	the	SRD	brainstem	nuclei	have	been	demonstrated	to	be	crucial	for	the	expression	of	DNIC	in	animals	and	CPM	in	humans	(Bouhassira	et	al	1992a,	Youssef	et	al	2015).	However,	complex	interactions	between	the	SRD,	higher	brain	structures	in	the	cortex,	and	midbrain	and	brainstem	structures	that	comprise	the	dorsolateral	funiculus	are	thought	to	be	required	for	the	activation	of	descending	monoaminergic	controls,	which	are	ultimately	responsible	for	mediating	DNIC	(See	Section	1.2.4)(Youssef	et	al	2016,	Bannister	and	Dickenson	2017).			As	the	MIA	model	is	a	robust	and	easily	inducible	animal	model	of	chronic	pain,	where	DNIC	is	functional	in	the	early	phase	but	abolished	in	the	late	phase,	this	model	offers	the	opportunity	for	assessing	changes	in	the	neuronal	activity	of	brain	structures	reported	to	be	involved	in	the	efficacy	of	DNIC.	In	human	CPM	studies,	fMRI	identified	a	reduction	of	activity	within	the	SRD	upon	a	concurrent	noxious	conditioning	stimulus,	which	was	responsible	for	mediating	the	CPM	response	(Youssef	et	al	2015).	Furthermore,	fMRI	highlighted	the	involvement	of	the	dlPFC,	CC,	amygdala	and	Pb	nucleus	in	modulating	the	CPM	response	(Youssef	et	al	2016).	Therefore,	this	technique	could	be	back	translated	to	the	MIA	model,	to	better	understand	changes	in	activity	occurring	in	the	brain	as	the	model	progresses	and	the	DNIC	system	becomes	abolished.	In	addition,	the	resolution	of	fMRI	allows	for	the	observation	of	neuronal	activity	across	the	entire	brain,	which	may	allow	for	a	better	understanding	of	how	brain	structures	interact	to	induce	a	DNIC	response,	and	highlight	any	alterations	in	these	connections	when	DNIC	is	lost	in	late	phase	animals	(Ferris	et	al	2006).			Despite	the	advantages	of	fMRI,	this	is	an	expensive	technique	that	requires	sophisticated	equipment.	Another	technique	that	could	be	employed	to	further	dissect	the	brain	structures	responsible	for	inducing	DNIC	is	brain	microinjections	and	blocking	
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or	activating	specific	brain	regions.	In	addition,	brain	microinjections	could	be	utilised	while	simultaneously	recording	DNIC	responses	in	WDR	neurons	using	in	vivo	single	unit	recordings,	which	would	be	difficult	to	combine	with	fMRI.	Therefore,	a	similar	approach	could	be	taken	as	that	presented	in	this	thesis,	where	the	DNIC	response	is	evaluated	in	convergent	WDR	neurons	while	pharmacologically	manipulating	the	monoaminergic	descending	controls.	However,	in	this	scenario	the	descending	controls	would	be	pharmacologically	manipulated	at	supraspinal	levels	rather	than	at	the	level	of	the	spinal	cord.	A	further	approach	could	be	to	take	electrophysiological	recordings	from	the	brain	structures	reported	to	be	involved	in	the	DNIC	system,	and	assess	any	changes	in	neuronal	activity	between	early	and	late	phase	MIA	animals.	Overall,	in	vivo	electrophysiological	techniques	provide	a	reliable	method	for	assessing	DNIC	in	animal	models	of	chronic	pain,	and	hold	potential	for	unraveling	the	roles	and	interactions	played	by	supraspinal	structures	in	activating	descending	controls	and	inducing	neuronal	inhibition	at	the	level	of	the	spinal	cord.			
7.5	Concluding	remarks		Firstly,	this	thesis	confirms	that	assessing	DNIC	responses	using	in	vivo	single	unit	recordings	of	convergent	WDR	neurons	in	the	dorsal	horn	provides	a	robust	and	reliable	technique	for	examining	the	functional	state	of	descending	controls	in	animal	models	of	chronic	pain.	Importantly,	as	DNIC	and	CPM	share	similar	pharmacology	and	altered	efficiencies	in	states	of	chronic	pain,	this	electrophysiological	technique	provides	a	useful	tool	for	forward	translation	to	the	clinic	(Yarnitsky	2010,	Yarnitsky	2015).	Overall,	the	work	presented	in	this	thesis	confirms	previous	findings	that	DNIC	represents	a	noradrenergic	endogenous	inhibitory	system	with	a	partly	descending	serotonergic	component	(Bannister	et	al	2017).			Secondly,	the	work	presented	in	this	thesis	investigated	an	MIA	induced	model	of	OA	in	the	rat.	It	was	demonstrated	that	although	both	early	and	late	phase	MIA	animals	develop	pain	in	both	the	knee	joint	and	ipsilateral	hind	paw,	only	late	phase	MIA	animals	display	significant	articular	cartilage	damage	in	the	knee	joint.	Due	to	the	joint	damage	induced	continuous	barrage	of	nociceptive	signaling	from	the	periphery	and	the	high	level	of	neuronal	plasticity	in	the	CNS,	it	is	likely	that	sensitivity	also	develops	in	second	order	neurons	in	the	dorsal	horn.	However,	the	results	presented	in	this	thesis	did	not	suggest	an	increase	in	evoked	activity	of	WDR	neurons,	which	contrasts	with	previous	findings	in	the	MIA	model	(Rahman	et	al	2009,	Burnham	and	Dickenson	2013)	
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However,	a	rise	in	the	mRNA	levels	of	the	pro-inflammatory	cytokine	IL-1β	and	the	microglia	biomarker	Iba1	were	detected	in	the	dorsal	horn	of	late	phase	animals	suggesting	the	development	of	microgliosis,	which	is	in	agreement	with	previous	findings	in	the	MIA	model	and	is	indicative	of	central	sensitisation	(Thakur	et	al	2012,	Ogbanna	et	al	2013).			Furthermore,	DNIC	is	abolished	in	late	phase	MIA	animals,	indicative	of	an	imbalance	in	descending	inhibitory	and	facilitatory	controls.	As	an	increased	serotonergic	facilitatory	drive	has	previously	been	demonstrated	in	MIA	animals,	and	blocking	spinal	5-HT3	receptors	has	been	demonstrated	to	restore	DNIC	in	a	model	of	neuropathy,	it	is	likely	there	is	an	increased	serotonergic	facilitatory	drive	acting	at	spinal	5-HT3	receptors	contributing	to	the	loss	of	DNIC	in	late	phase	MIA	animals	(Rahman	et	al	2009,	Bannister	et	al	2015).	A	study	in	this	thesis	demonstrated	that	DNIC	expression	could	be	restored	in	late	phase	animals	with	the	NRI	Tapentadol,	suggesting	a	decreased	noradrenergic	inhibitory	drive	also	contributes	to	the	loss	of	DNIC.	In	addition,	activating	spinal	5-HT7	receptors	restored	DNIC	expression	in	late	phase	MIA	animals.	As	the	5-HT7	receptors	are	colocalised	with	GABAergic	inhibitory	interneurons	and	disinhibition	is	reported	in	states	of	central	sensitisation,	it	is	likely	there	is	decreased	serotonergic	inhibitory	tone	acting	at	spinal	5-HT7	receptors	and	a	subsequent	decrease	in	the	activation	of	inhibitory	interneurons	in	the	dorsal	horn	(Todd	2012,	Brenchat	2010,	Viguier	et	al	2012).	A	general	schematic	of	the	peripheral	joint	damage	and	centrally	driven	chronic	pain	is	shown	in	Figure	7.2.	Overall,	the	studies	presented	in	this	thesis	indicate	that	restoring	the	balance	in	descending	inhibitory	and	facilitatory	controls	through	pharmacologically	manipulating	monoaminergic	signaling	is	an	effective	approach	for	providing	analgesia	in	the	MIA	model	of	OA.			I	hope	the	studies	presented	in	this	thesis	further	our	understanding	of	how	modulation	of	descending	controls	can	influence	the	chronic	pain	associated	with	OA.	I	hope	through	assessing	CPM	efficiency	in	the	OA	clinic,	patient	segmentation	and	a	personalised	medicine	approach	could	be	adopted	such	that	each	individual	patient	could	receive	the	most	appropriate	analgesic	therapy.			
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Figure	7.2.	The	overall	schematic	of	joint	damage	induced	peripheral	sensitisation,	central	
sensitisation	and	modulation	of	descending	controls.	The	MIA	induced	joint	damage	observed	in	late	phase	MIA	animals	results	in	a	continuous	barrage	of	nociceptive	signaling	from	the	periphery	to	the	dorsal	horn,	which	can	lead	to	an	increased	sensitivity	of	second	order	neurons	and	the	development	of	central	sensitisation.	Subsequently,	an	imbalance	in	descending	controls	develops,	such	that	there	is	a	decreased	noradrenergic	and	serotonergic	inhibitory	drive	acting	at	spinal	α2-adrenergic	and	5-HT7	receptors,	and	an	increased	serotonergic	facilitatory	
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drive	acting	at	spinal	5-HT3	receptors.	The	overall	consequence	is	a	loss	of	DNIC,	potentially	due	to	altered	signaling	in	the	brain	structures	reported	to	be	involved	in	the	efficacy	of	DNIC.	The	brain	structures	presented	in	red	have	been	shown	to	directly	impact	DNIC,	while	the	brain	structures	presented	in	blue	are	thought	to	play	an	indirect	role	on	the	expression	of	DNIC.					
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8.	Appendix	
	
8.1	Pharmacology	controls	
	Pharmacological	controls	were	carried	out	to	ensure	any	drug	effects	reported	on	neuronal	firing	were	due	to	drug	actions	rather	than	the	solution	they	were	delivered	in.	Pre-conditioned	neuronal	responses	and	DNIC	responses,	calculated	as	a	reduction	in	mechanically	evoked	neuronal	firing	induced	with	a	concurrent	noxious	ear	pinch,	were	tested.	A	DNIC	trial	was	carried	before	and	after	a	subcutaneous	injection	of	saline	(250μL)(Figure	8.1A),	the	spinal	application	of	saline	(50	μL)	(Figure	8.1B),	and	the	spinal	application	of	vehicle	(97%	normal	saline,	2%	cremaphor,	1%	DMSO)(50	μL)(Figure	8.1C).	The	saline	and	vehicle	solutions	had	no	effect	on	pre-conditioned	mechanically	evoked	neuronal	firing	or	on	the	level	of	neuronal	inhibition	induced	by	DNIC.		
	
Figure	8.1.	Pharmacology	controls.	A)	The	topical	application	of	vehicle	to	the	cord	had	no	effect	on	pre-conditioned	mechanically	evoked	neuronal	firing	or	the	neuronal	inhibition	induced	
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by	DNIC.	B)	A	subcutaneous	injection	of	saline	had	no	effect	on	pre-conditioned	mechanically	evoked	neuronal	firing	or	the	neuronal	inhibition	induced	by	DNIC.	C)	A	topical	application	of	saline	had	no	effect	on	pre-conditioned	mechanically	evoked	neuronal	firing	or	the	neuronal	inhibition	induced	by	DNIC.	Two-way	ANOVA	with	Bonferroni	correction.	*P<-0.05,	**P<0.01,	***P<0.001.		
8.2	MIA	injected	animals	and	saline	injected	sham	control	
weights	The	MIA	injection	produced	joint	damage	and	pain-like	behaviour,	but	other	than	that	we	want	the	animals	to	remain	in	relatively	good	health.	To	monitor	this	we	measure	the	weights	of	the	animals	over	the	course	of	the	model	and	check	the	animals	are	gaining	weight	in	course	with	saline	injected	sham	controls.	No	statistical	difference	was	found	between	the	weights	of	early	phase	MIA	injected	and	saline	injected	animals	over	the	course	of	the	model	(Figure	8.2A).	No	statistical	difference	was	found	between	the	weight	of	late	phase	MIA	injected	animals	and	saline	injected	sham	controls	over	the	course	of	the	model	(Figure	8.2B).			
	
Figure	8.2	The	weights	on	MIA	injected	and	saline	injected	sham	controls	over	the	course	
of	the	model.	A)	There	was	no	difference	between	the	weights	of	early	phase	MIA	injected	animals	and	saline	injected	sham	controls	over	the	course	of	the	model	(EP	MIA	n=10,	EP	Sham	n=13).	B)	There	was	no	difference	between	the	weights	of	late	phase	MIA	injected	animals	and	saline	injected	sham	controls	over	the	course	of	the	model	(LP	MIA	n=8,	LP	Sham	n	=10).	Two-way	ANOVA	with	Bonferoni	correction.			
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8.3	qPCR	primer	validation	
	When	new	primers	were	designed	using	pre-established	primer-blast	criteria,	a	serial	dilution	of	each	primer	was	created	to	produce	a	standard	curve.	The	resultant	PCR	product	was	then	ran	on	an	agarose	gel	using	electrophoresis	to	confirm	that	only	one	product	of	correct	length	was	being	amplified.	All	of	the	primers	used	for	this	thesis	that	were	designed	in	this	way,	only	one	band	was	produced,	and	these	were	all	of	appropriate	length	as	determined	by	comparing	the	band	to	a	DNA	ladder	(Figure	8.3).		
	
Figure	8.3	Primer	validations.	For	all	primers	designed	for	this	thesis,	when	the	PCR	products	were	ran	on	an	agarose	gel	only	one	band	was	produced	of	the	appropriate	size	indicating	the	primers	are	resulting	in	the	amplification	of	the	correct	product.			
8.4	Fast	Blue	neuronal	tracer		To	confirm	that	the	Fast	Blue	neuronal	tracer	was	only	being	taken	up	by	primary	afferents	innervating	the	knee	the	contralateral	lumbar	DRGs	were	also	taken	and	checked	for	unspecific	staining.	There	were	no	Fast	Blue	positive	cell	bodies	in	the	L3-L5	DRGs	contralateral	to	injection	(Figure	8.4).		
	
Figure	8.4	Fast	Blue	staining	in	the	lumbar	DRGs	contralateral	to	injection.	No	Fast	Blue	positive	cell	bodies	were	observed	in	the	L3,	L4	or	L5	DRGs	contralateral	to	Fast	Blue	injection.		
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